tiprankstipranks
Bolt Biotherapeutics (BOLT)
NASDAQ:BOLT
Holding BOLT?
Track your performance easily

Bolt Biotherapeutics (BOLT) Financial Statements

203 Followers

Bolt Biotherapeutics Financial Overview

Bolt Biotherapeutics's market cap is currently ―. The company's EPS TTM is $-1.708; its P/E ratio is -0.33; Bolt Biotherapeutics is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 1.14M$ 1.27M$ 5.27M$ 2.09M$ 2.53M
Gross Profit$ 1.14M$ 1.27M$ 5.27M$ 2.09M$ 2.53M
EBIT$ -15.18M$ -21.20M$ -10.81M$ -19.77M$ -18.18M
EBITDA$ -13.93M$ -18.92M$ -10.61M$ -19.30M$ -17.72M
Net Income Common Stockholders$ -15.18M$ -21.20M$ -10.81M$ -17.90M$ -16.26M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 53.80M$ 73.70M$ 91.35M$ 102.19M$ 119.72M
Total Assets$ 109.33M$ 124.18M$ 142.89M$ 159.78M$ 175.35M
Total Debt$ 18.18M$ 18.89M$ 19.57M$ 20.22M$ 20.86M
Net Debt$ -35.62M$ -54.81M$ -71.78M$ -81.97M$ -98.87M
Total Liabilities$ 37.30M$ 38.32M$ 38.73M$ 47.04M$ 47.10M
Stockholders Equity$ 72.03M$ 85.86M$ 104.16M$ 112.74M$ 128.26M
Cash Flow-
Free Cash Flow$ -13.86M$ -16.14M$ -16.75M$ -14.27M$ -16.91M
Operating Cash Flow$ -13.97M$ -16.14M$ -16.75M$ -14.27M$ -16.75M
Investing Cash Flow$ 17.14M$ 18.00M$ 10.20M$ 15.81M$ 12.66M
Financing Cash Flow-$ 79.00K-$ 106.00K-
Currency in USD

Bolt Biotherapeutics Earnings and Revenue History

Bolt Biotherapeutics Debt to Assets

Bolt Biotherapeutics Cash Flow

Bolt Biotherapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis